Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04332744 |
| Title | Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First) (ZZ-First) |
| Acronym | ZZ-First |
| Recruitment | Active, not recruiting |
| Gender | male |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | MedSIR |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Institut Català d'Oncologia Badalona | Badalona | Spain | Details | |||
| Hospital Clínic i Provicial de Barcelona | Barcelona | Spain | Details | |||
| Hospital del Mar | Barcelona | Spain | Details | |||
| Hospital Vall d'Hebrón | Barcelona | Spain | Details | |||
| Hospital Universitario 12 de Octubre | Madrid | Spain | Details | |||
| Hospital Universitario Virgen de la Victoria | Málaga | Spain | Details | |||
| Instituto Valenciano de Oncología (IVO) | Valencia | Spain | Details | |||
| Hospital Universitario Miguel Sevet | Zaragoza | Spain | Details |